Ref.: BL-RE-093374Manufacturer ref.: EM16RBX5 5 x 96 tests
€2,950.00 excl. VAT
Mouse CD80 quantitates mouse CD80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse CD80.
Accession number
Antigène B7-1 d’activation ; protéine B7 ; protéine B7 ; B7.1 ; B71 ; B7-1 ; protéine B7-1 ; antigène B7 d’activation des lymphocytes B ; Cd28l ; CD28LG ; CD28LG1 ; CD80 ; Cd80, un homologue chez le rat du ligand CD28/CTLA - 4 humain (B7-1) ; antigène CD80 ; antigène CD80 ; antigène CD80 (ligand 1 d’antigène CD28 1, antigène B7-1) ; molécule Cd80 ; précurseur protéique CD80 ; facteur costimulatoire CD80 ; variante de la molécule de costimulation IgV-CD80 ; contre-récepteur CTLA-4 B7.1 ; LAB7 ; Ly53 ; Ly-53 ; MIC17 ; sCD 80 ; SCD80 ; CD 80 soluble ; CD80 soluble ; molécule de co-stimulation des cellules T ; protéine de co-stimulation des cellules T B7-1 ; antigène d’activation des lymphocytes T CD80 ; TS/A-1 ; TSA1
Dose range
28 to 7.000 pg/ml
Sensitivity of the dosage
28 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Mouse CD80 quantitates mouse CD80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse CD80.
Mouse CD80 quantitates mouse CD80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse CD80.
CD80 (B7-1) and CD86 (B7-2) are critical CD28 costimulation molecule ligands of T cells and CTLA-4 inhibitor receptor (CD152). Both B7 molecules are expressed on professional antigen-presenting cells and are essential for T cell activation. These two molecules can also replace one another in this process. CD80 is rapidly induced on the surface of B cells activated in vitro, with B cell lines transformed by the Epstein Barr virus (EBV), with Burkitt lymphoma cell lines, with newly isolated follicular B lymphoma cells, T cells, and monocytes. The B7-1 B-Dactivation antigen provides regulatory signals for T-cell lymphocytes as a result of binding to CD28 and CTLA4 ligands in T cells. Diseases associated with CD80 protein dysfunction include epidermoid carcinoma of the gallbladder and myocarditis.
Sensitivity
Sensitivity of the dosage: 28 pg/ml.
Measurement range
Dose range: 28 to 7,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: CD80 (B7-1).
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17185609
Specifications
Accession number
Antigen B7-1 d-activation; protein B7; protein B7; B7.1; B71; B7-1; protein B7-1; antigen B7 of activation of B lymphocytes; Cd28l; CD28LG; CD28LG1 ; CD80; Cd80, a homologous rat CD28/CTLA - 4 human (B7-1) ; CD80 antigen ; CD80 antigen ; CD80 antigen (ligand 1 d)